Literature DB >> 28821193

Therapeutic Plasma Exchange and Its Impact on Drug Levels: An ACLPS Critical Review.

Caleb W Cheng1, Jeanne E Hendrickson1,2, Christopher A Tormey1,3, Davinder Sidhu4.   

Abstract

OBJECTIVES: To examine and summarize the current literature on the effects of therapeutic plasma exchange on medication levels.
METHODS: Literature review was performed via searches of the Cochrane Database and PubMed-MEDLINE (1996 to August 2016) looking for all case reports, case series, and human randomized controlled trials involving therapeutic plasma exchange (TPE)-associated drug removal.
RESULTS: Approximately 60 peer-reviewed articles were identified with the majority being case reports; no randomized controlled trials were identified. These reports and the authors' own experiences were used to derive practical guidance regarding the effect of TPE on circulating drug levels.
CONCLUSIONS: There were several limitations with existing studies, many of which relate to procedural and/or clinical properties of patients undergoing TPE. As such, additional studies are needed before definitive guidelines can be established. There is clear need for development of consensus and additional investigations in this domain. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Pathology consultation; Pharmacokinetics; Therapeutic plasma exchange

Mesh:

Year:  2017        PMID: 28821193     DOI: 10.1093/ajcp/aqx056

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  The Effect of Therapeutic Plasma Exchange on COVID-19 Therapy.

Authors:  Cansu GÖncÜoĞlu; Fatma Nisa Balli; Aygin Bayraktar EkİncİoĞlu
Journal:  Turk J Pharm Sci       Date:  2020-10-30

Review 2.  Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.

Authors:  Sherif Hanafy Mahmoud; Jessica Buhler; Eric Chu; Suzie A Chen; Theresa Human
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

3.  Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy.

Authors:  Danica Michaličková; Jan Miroslav Hartinger; Zuzana Hladinová; Vladimíra Bednářová; Barbora Szonowská; Vladimír Polakovič; Andreas Matthios; Vladimír Tesař; Ondřej Slanař; Elke H J Krekels
Journal:  Eur J Clin Pharmacol       Date:  2021-08-19       Impact factor: 2.953

Review 4.  PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines.

Authors:  Mohammed Safi; Hyat Ahmed; Mahmoud Al-Azab; Yun-Long Xia; Xiu Shan; Mohammed Al-Radhi; Abdullah Al-Danakh; Abdullah Shopit; Jiwei Liu
Journal:  J Adv Res       Date:  2020-10-03       Impact factor: 10.479

Review 5.  Plasma exchange in the intensive care unit: a narrative review.

Authors:  Philippe R Bauer; Marlies Ostermann; Lene Russell; Chiara Robba; Sascha David; Bruno L Ferreyro; Joan Cid; Pedro Castro; Nicole P Juffermans; Luca Montini; Tasneem Pirani; Andry Van De Louw; Nathan Nielsen; Julia Wendon; Anne C Brignier; Miet Schetz; Jan T Kielstein; Jeffrey L Winters; Elie Azoulay
Journal:  Intensive Care Med       Date:  2022-08-12       Impact factor: 41.787

6.  Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations.

Authors:  Ian Baldwin; Sarah Todd
Journal:  J Clin Apher       Date:  2022-04-06       Impact factor: 2.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.